MICHAEL ROBICHAUX: Open Payments
NPI 1003301532 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,230 in 54 payments from 14 companies in 2025. Trend: 2023 $881 · 2024 $896 · 2025 $1,230
Food & beverage: $1,230
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 7 | $359 |
| Novartis Pharmaceuticals Corporation | 8 | $162 |
| E.R. Squibb & Sons, L.L.C. | 7 | $118 |
| Amgen Inc. | 6 | $104 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $91 |
| Regeneron Healthcare Solutions, Inc. | 3 | $65 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $65 |
| Actelion Pharmaceuticals US, Inc. | 2 | $52 |
| PFIZER INC. | 2 | $48 |
| SCPHARMACEUTICALS INC. | 3 | $47 |
Products named: Assure WCD, LEQVIO, REPATHA, ELIQUIS, JARDIANCE, CAMZYOS, EVKEEZA, LifeVest.
Industry payments across LA — which companies pay providers there.
